Abstract
Hypertension(HT) due to RAS complicates 5-10% of renal transplants and jeopardizes graft function. Alternatives to surgery in immune suppressed transplant recipients are desirable. 4 subjects developed HT with hyperreninemia within 1 yr post transplant. Significant RAS was demonstrated angiographically in each. Therapy with percutaneous transluminal angioplasty produced:
3 subjects remain normotensive, on no RX, 3 to 11 mos post-dilatation. Repeat arteriography at 11 mos shows no recurrence of RAS in case 1. No serious complications occurred.
We concluded that percutaneous transluminal angioplasty offers an acceptable alternative to surgery in renal transplant recipients with hypertension due to renal artery stenosis.
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Macdonell, R., Gerlock, A., Johnson, H. et al. 1520 PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY IN TRANSPLANT RENAL ARTERY STENOSIS (RAS). Pediatr Res 15 (Suppl 4), 696 (1981). https://doi.org/10.1203/00006450-198104001-01543
Issue Date:
DOI: https://doi.org/10.1203/00006450-198104001-01543